Please login to the form below

Wilmington Healthcare appoints new Account Director

Healthcare intelligence provider Wilmington Healthcare, which incorporates Binley’s, NHiS, Wellards and HSJ, has strengthened its salesforce with the appointment of Gareth Thurston as Account Director.

In his new post, Gareth will be overseeing a number of key accounts across the Wilmington Healthcare portfolio and ensuring that the relevant specialist teams meet their objectives.

Gareth who has worked in sales and marketing roles in the healthcare industry for nearly 30 years, joins Wilmington Healthcare from Cello Health Consulting Ltd, where he was a consultant.

Prior to that, Gareth spent nearly 10 years at Novartis Pharmaceuticals UK Limited, where he held a number of different roles, including Marketing Manager and Franchise Lead for the company’s transplantation portfolio. His final post at the company was Brand Lead, Ophthalmology.   Before joining Novartis, Gareth held senior sales and product manager positions at Gilead Sciences Ltd in their anti-infective franchise.

Gareth Thomas, Managing Director of Wilmington Healthcare, said: “Having worked in sales and marketing roles in the healthcare industry for nearly 30 years, Gareth Thurston brings a wealth of experience to his new job.

“He will play an important role in supporting our clients to achieve greater success, whilst helping our business to continue to go from strength to strength. We are very pleased to welcome him to our team.” 


Gareth Thurston

26th September 2017

Share

Tags

Company Details

Wilmington Healthcare

01268 495600

Contact Website

Address:
Beechwood House
2-3 Commercial Way
Christy Close
Southfields
Basildon
SS15 6EF
United Kingdom

Latest content on this profile

Covid-19: how is it impacting on the NHS Long-term Plan?
Oli Hudson and Paul Midgley, of Wilmington Healthcare, explain how coronavirus has expedited some parts of the plan but put others in jeopardy
Wilmington Healthcare
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it
Wilmington Healthcare
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve
Wilmington Healthcare
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond
Wilmington Healthcare
2019: A pivotal year for the NHS
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the key changes in the NHS in 2019
Wilmington Healthcare
Early diagnosis underpins NHS cancer strategy
Paul Midgley, Oli Hudson and Sarah Shield, of Wilmington Healthcare, explore how the NHS is tackling cancer in line with the Long-term Plan
Wilmington Healthcare